What regulatory guidelines apply to 3,6-Dibromopyridazine (CAS: 17973-86-3)?

3,6-Dibromopyridazine (CAS: 17973-86-3) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for potential skin and eye irritation. It is also subject to the REACH regulation in the European Union, which requires registration of substances above 1 tonne per year. In the United States, it is regulated by the FDA and EPA under the Toxic Substances Control Act (TSCA) and the Emergency Planning and Community Right-to-Know Act (EPCRA).